Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

3D-Printed tumors could personalize liver cancer treatment

NCT ID NCT07437859

First seen Mar 04, 2026 · Last updated May 22, 2026 · Updated 16 times

Summary

This study explores whether 3D bioprinting can create realistic liver cancer models from patient tissue. These models are used to test chemotherapy drugs before giving them to patients, aiming to predict which treatments work best. The goal is to improve personalized treatment and understand why some cancers resist drugs. About 60 adults with primary liver cancer are participating.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY LIVER CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Peking Union Medical College hospital

    Beijing, Beijing Municipality, 100730, China

Conditions

Explore the condition pages connected to this study.